Development of BTK inhibitors for the treatment of B-cell malignancies
Crossref DOI link: https://doi.org/10.1007/s12272-019-01124-1
Published Online: 2019-01-31
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Hyung-Ook http://orcid.org/0000-0001-7700-1413
Text and Data Mining valid from 2019-01-31
Article History
Received: 14 May 2018
Accepted: 19 January 2019
First Online: 31 January 2019
Compliance with ethical standards
:
: There is no conflict of interest.